Philip J. Lee

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Mike Rhee, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philip J. Lee:

Company Role Class Num Shares Value Price $ Report Date Ownership
Senti Biosciences, Inc.\ Chief Technology Officer Common Stock 936,424 $4,082,809 $4.36 08 Jun 2022 Direct
Senti Biosciences, Inc. Chief Technology Officer Stock Option (Right to Buy) 195,000 01 Feb 2023 Direct

Insider Reports Filed by Philip J. Lee

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNTI Senti Biosciences, Inc. 01 Feb 2023 1 $0 4 Chief Technology Officer 02 Feb 2023, 16:21
SNTI Senti Biosciences, Inc.\ 08 Jun 2022 0 $0 3 Chief Technology Officer 15 Jun 2022, 18:01